Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jul 11:7:1004.
doi: 10.3389/fpls.2016.01004. eCollection 2016.

Neuroprotective Activity of Hypericum perforatum and Its Major Components

Affiliations
Review

Neuroprotective Activity of Hypericum perforatum and Its Major Components

Ana I Oliveira et al. Front Plant Sci. .

Abstract

Hypericum perforatum is a perennial plant, with worldwide distribution, commonly known as St. John's wort. It has been used for centuries in traditional medicine for the treatment of several disorders, such as minor burns, anxiety, and mild to moderate depression. In the past years, its antidepressant properties have been extensively studied. Despite that, other H. perforatum biological activities, as its neuroprotective properties have also been evaluated. The present review aims to provide a comprehensive summary of the main biologically active compounds of H. perforatum, as for its chemistry, pharmacological activities, drug interactions and adverse reactions and gather scattered information about its neuroprotective abilities. As for this, it has been demonstrated that H. perforatum extracts and several of its major molecular components have the ability to protect against toxic insults, either directly, through neuroprotective mechanisms, or indirectly, through is antioxidant properties. H. perforatum has therefore the potential to become an effective neuroprotective therapeutic agent, despite further studies that need to be carried out.

Keywords: Hypericum perforatum; antioxidant activity; compounds; extracts; neuroprotection.

PubMed Disclaimer

References

    1. Abbott N. J. (2002). Astrocyte-endothelial interactions and blood-brain barrier permeability. J. Anat. 200 629–638. 10.1046/j.1469-7580.2002.00064.x - DOI - PMC - PubMed
    1. Agostinis P., Vantieghem A., Merlevede W., de Witte P. A. (2002). Hypericin in cancer treatment: more light on the way. Int. J. Biochem. Cell Biol. 34 221–241. 10.1016/S1357-2725(01)00126-1 - DOI - PubMed
    1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G. M., et al. (2000). Inflammation and Alzheimer’s disease. Neurobiol. Aging 21 383–421. 10.1016/S0197-4580(00)00124-X - DOI - PMC - PubMed
    1. Albert D., Zundorf I., Dingermann T., Muller W. E., Steinhilber D., Werz O. (2002). Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase. Biochem. Pharmacol. 64 1767–1775. 10.1016/S0006-2952(02)01387-4 - DOI - PubMed
    1. Alia M., Mateos R., Ramos S., Lecumberri E., Bravo L., Goya L. (2006). Influence of quercetin and rutin on growth and antioxidant defense system of a human hepatoma cell line (HepG2). Eur. J. Nutr. 45 19–28. 10.1007/s00394-005-0558-7 - DOI - PubMed